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Introduction
Loeys-Dietz syndrome (LDS) is a rare, recently
characterized autosomal-dominant genetic condi-
tion with marfanoid habitus, belonging to the Mar-
fan-related disorders, a subset of connective tissue
diseases with skeletal, ocular, and cardiovascular
involvement. The initial report on LDS appeared
in 2005 (Loeys et al. 2005). The authors character-
ized 10 families with the syndrome and found het-
erozygous mutations in the genes encoding
transforming growth factor beta receptor I
(TGFBR1) or II (TGFBR2). A year later, Loeys
et al. (2006) described 30 additional individuals
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Abstract. We report on a 2-year-old Polish girl with typical manifestations of Loeys-Dietz syndrome (LDS), a
rare genetic condition belonging to the group of Marfan-related disorders. The characteristic LDS symptoms ob-
served in the girl included craniofacial dysmorphism (craniosynostosis, cleft palate, hypertelorism),
arachnodactyly, camptodactyly, scoliosis, joint laxity, talipes equinovarus, translucent and hyperelastic skin, and
umbilical hernia. Mild dilatation of the ascending aorta and tortuous course of the left internal carotid artery were
recognized during her second year of life. Molecular genetic testing revealed a heterozygous missense mutation
(c.1582C>T, p.R528C) in the transforming growth factor beta receptor II gene (TGFBR2). This mutation has
been previously associated with LDS in 5 unrelated cases, and was never reported in patients with other Mar-
fan-related disorders. Comparison of the phenotypes of our patient and these 5 individuals with c.1582C>T
showed that only the hallmark triad of the syndrome – consisting of hypertelorism, aortic root dilatation/aneu-
rysm, and cleft palate or bifid uvula – was present in all 6 cases. Interestingly, none of the 5 individuals who un-
derwent psychological evaluation showed developmental delay. The pattern of all other LDS features showed
interindividual variability. Our data support the recently reported observation that symptoms of LDS can develop
at a very young age, making early diagnosis and management essential for these patients. This is the first report
on a Polish infant with typical LDS symptoms caused by a TGFBR2 mutation.
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with the diagnosis of typical LDS. Nearly all pa-
tients presented with a triad of symptoms, com-
prising arterial tortuosity and aneurysms,
hypertelorism, and bifid uvula or cleft palate, and
all harboured a TGFBR1 or a TGFBR2 heterozy-
gous mutation. In addition, in the same work,
Loeys et al. (2006) studied a cohort of 40 patients
with a vascular Ehlers-Danlos syndrome-like
(EDS IV) phenotype without characteristic colla-
gen type III (COL3A1) anomalies or craniofacial
dysmorphism typical of LDS, and identified het-
erozygous mutations either in TGFBR1 or
TGFBR2 in 12 probands. LDS type I was pro-
posed to stand for the syndrome with typical facial
dysmorphic features, and LDS type II to describe
the syndrome without craniofacial affectation.
Both entities are characterized by aggressive arte-
rial aneurysms (Loeys et al. 2006). Occasional
findings in LDS type I encompass
craniosynostosis, congenital heart defect, struc-
tural brain abnormality, hydrocephaly, and mental
retardation/developmental delay (Loeys et al.
2005, 2006; Stheneur et al. 2008). In order to dis-
tinguish between the genetic background of LDS
type I and type II, additional nomenclature subdi-
vides cases into subtype A, resulting from
TGFBR1 mutations, and subtype B, caused by
TGFBR2 mutations (Loeys et al. 2006). Currently,
with a growing number of LDS patients, a detailed
clinical phenotype of the syndrome is beginning to
emerge.
In this report, we describe a Polish girl with
typical LDS type I caused by a recurrent TGFBR2
mutation (p.R528C). We refer her clinical picture
to the phenotype of 5 other LDS cases resulting
from the same mutation, and to the total LDS
type I population reported to date in the literature.
Case report
The proband, a 2-year-old girl of Polish descent,
was born by elective Caesarean section after un-
eventful pregnancy (G2P2) at 39 weeks of gesta-
tion to nonconsanguineous and healthy parents:
30-year-old mother and 33-year-old father. At
birth, her weight was 2800 g (10th–25th percen-
tile), length 51 cm (75th–90th percentile), head
circumference 34 cm (50th percentile), and Apgar
score was 10 at 1, 3, and 5 minutes. Physical ex-
amination after birth showed craniofacial
dysmorphism with prominent forehead, cleft soft
and hard palate, and long slender fingers. An ultra-
sound scan of the brain at 3 months revealed exter-
nal hydrocephaly and a subependymal cyst (8 mm
in diameter) of the right lateral ventricle. On re-
peated ultrasound brain controls, mild dilatation of
the lateral ventricles, with gradually decreasing
external hydrocephaly were noted. Hearing tests
performed at the age of 8 months showed initially
right-sided and subsequently bilateral conductive
hypoacusis. The girl was referred to our genetics
clinic for diagnosis and first investigated at the age
of 9 months. Upon examination, she presented
with craniofacial dysmorphic features comprising
scaphocephalic shape of the head with frontal
bossing due to craniosynostosis (premature clo-
sure of sagittal suture), proptosis, hypertelorism,
mild epicanthal folds, blue sclerae, short nose with
flat nasal bridge, micrognathia, cleft hard and soft
palate, and thin upper lip (Figures 1a, b, c, d). Her
length and head circumference was then 65 cm
(<3rd percentile) and 45 cm (50th–75th percen-
tile), respectively. Enlarged, prominent anterior
fontanelle and widening of subcutaneous veins on
the skull were conspicuous (Figure 1c). Further-
more, arachnodactyly of the hands and feet,
camptodactyly of the 5th fingers (Figure 1e), joint
laxity, hyperelastic translucent skin, and umbilical
hernia were noted (Figure 1a). Psychomotor de-
velopment was apparently normal. Cardiac
sonography at 16 months revealed a mild dilata-
tion of the ascending aorta and a trace patent fora-
406 A. Jamsheer et al.
Figure 1A. A whole view of the proband, showing
prominent umbilical hernia (age 9 months)
men ovale (PFO) without haemodynamically
significant interatrial shunting. The girl was rein-
vestigated in the genetics clinic at 19 months of
age. Dysmorphic features seen during her first
evaluation were still present. Her growth was
slightly retarded, with body weight of 9.8 kg
(< 3rd percentile), height of 77.5 cm (3rd–10th
percentile), and head circumference of 48.5 cm
(50th–75th percentile). According to anamnesis,
developmental milestones were achieved on time,
with independent sitting at 7, walking at 12, and
expressive speech (several first words) at
12 months. MRI of the brain showed no structural
malformation, but magnetic resonance
angiography of the brain vessels at 23 months of
age disclosed abnormal pars cavernosa of the left
internal carotid artery, described as most probable
tortuous course of the artery, or less likely arterial
aneurysm. Chromosomal analysis on peripheral
blood lymphocytes with resolution of 550 bands
per haploid genome revealed a normal female
karyotype (46,XX). Except mild hypertelorism in
the father, both parents had no signs of
craniofacial dysmorphism. Family history was
noncontributory.
To confirm our clinical diagnosis of LDS, we
performed molecular genetic testing of the
TGFBR1 and TGFBR2 genes (informed consent of
the parents was obtained prior to genetic testing).
All exons and flanking intronic regions of both
genes were amplified and sequenced according to
Matyas et al. (2006). In our proband, we detected a
heterozygous substitution of C>T at position 1582
(c.1582C>T) in exon 7 (Figure 2), resulting in a
missense mutation at codon 528 in the C-terminal
fragment of the TGFBR2 protein (p.R528C). The
mutation affects a highly conserved amino acid
residue (arginine) and was predicted to damage
protein function (cf. Matyas et al. 2006). How-
ever, the possibility that c.1582C>T has an effect
on mRNA expression or splicing cannot be ex-
cluded. Additionally, 2 known TGFBR2
polymorphisms, one homozygous for
IVS2+7A>G (rs1155705) and the other heterozy-
gous for IVS3-4T>A (rs11466512), were identi-
fied. Deletions/duplications of all TGFBR1 and
TGFBR2 exons were excluded by multiplex liga-
tion-dependent probe amplification (MLPA) us-
ing the SALSA kits P065 and P148, as described
LDS due to p.R528C TGFBR2 mutation 407
Figure 1C. Lateral view of the proband (abnormal skull
shape with frontal bossing, micrognathia, widened veins,
and translucent skin on the head)
Figure 1B. Facial dysmorphic features of the proband
(hypertelorism, prominent forehead, short nose with flat
nasal bridge, thin upper lip, and discrete epicanthal folds)
Figure 1D. Cleft soft and hard palate seen in the proband
Figure 1E. Arachnodactyly of the hand and
camptodactyly of the 5th finger noted in the proband
elsewhere (Matyas et al. 2007). The mutation
c.1582C>T was not detected in the leukocyte
DNAs of the unaffected parents, but (germline)
mosaicism cannot be excluded. Haplotype analy-
sis using 8 short tandem repeat markers on 6 dif-
ferent chromosomes confirmed paternity and thus
de novo occurrence of c.1582C>T (p.R528C).
Discussion
So far, a series of about 80 LDS patients have been
described in the literature, with a majority of adult
individuals (e.g. Loeys et al. 2005; 2006; Sakai
et al. 2006; Singh et al. 2006; Matyas et al. 2006;
Akutsu et al. 2007; Togashi et al. 2007; LeMaire
et al. 2007; Aalberts et al. 2008; Stheneur et al.
2008; Frederic et al. 2008). The clinical phenotype
of LDS overlaps to some extent with Marfan syn-
drome (MFS), including the propensity for aortic
aneurysm and dissection, and thus the condition
may pose diagnostic difficulties and still be
lumped together with MFS (Ades et al. 2006). In
addition to the phenotypic overlap, MFS and LDS
share partially common genetic background. Be-
sides the FBN1 mutations responsible for more
than 90% of the cases, MFS with or without fulfil-
ment of Ghent criteria, can be caused by mutations
in the TGF receptor genes (Mizuguchi et al. 2004;
Disabella et al. 2006; Matyas et al. 2006; Singh et
al. 2006; Stheneur et al. 2008). LDS is caused
solely by TGFBR1 or TGFBR2 mutations, and as a
result it seems to have a distinct natural history.
With respect to MFS, the syndrome conveys a
higher risk of arterial dissection, without consider-
able dilatation of the affected vessel, and is char-
acterized by marked arterial tortuosity or
aneurysms throughout the arterial tree. Further-
more, the mean age of a deadly vascular episode
without treatment is estimated at 26 years, which
is at least a few years earlier than in MFS. There-
fore, it is of great relevance to make a distinction
between these 2 conditions. Early diagnosis is the
prerequisite for adequate management of LDS pa-
tients. Thorough repeated clinical assessment of the
cardiovascular system (echocardiography,
angiography, MRI angiography), along with aggres-
sive surgical repair of aneurysms, should be under-
taken to prevent future vascular events (Yetman et al.
2007).
Here, we present a female infant with typical
manifestation of LDS type I, initially seen and
evaluated by us at the age of 9 months. Mutational
analysis of the TGFBR1 and TGFBR2 genes re-
vealed a de novo TGFBR2 missense mutation
(c.1582C>T, p.R528C). This mutation has been
previously described in 5 unrelated LDS cases
(Loeys et al. 2005; 2006; LeMaire et al. 2007;
Stheneur et al. 2008). Interestingly, to our knowl-
edge, the mutation has never been identified in the
individuals with MFS or other MFS-related disor-
ders (Shprintzen-Goldberg syndrome, thoracic
aortic aneurysm and dissection), suggesting its
specificity to LDS. Comparison of the phenotypes
of all 6 individuals with c.1582C>T (p.R528C)
showed that only the hallmark triad of the syn-
drome – consisting of hypertelorism, aortic root
dilatation/aneurysm, and cleft palate or bifid uvula
– was present in all the patients. The above fea-
tures occur with the highest frequencies in overall
LDS type I population, regardless of the mutation.
Interestingly, none of the 5 affected individuals
who underwent psychological evaluation pre-
sented with psychomotor retardation. The overall
incidence of developmental delay in a subset of 67
LDS type I patients was estimated to be about 10%
(Table 1). The lack of this feature in the patients
with p.R528C TGFBR2 mutation most probably
results from the small number of individuals in our
study. On the other hand, it is also possible that the
mutation has little impact on neurocognitive de-
velopment. The pattern of other LDS type I char-
acteristics caused by the p.R528C TGFBR2
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Figure 2. Partial forward sequence of the TGFBR2 gene (exon 7) flanking the mutation c.1582C>T (p.R528C) in our
patient and her parents. Arrows indicate the site of mutation
mutation showed more interindividual variability
(Table 1).
Although our patient was very young, she pre-
sented with mild aortic root dilatation, while mag-
netic angiography of the brain vessels disclosed a
corkscrew course (or aneurysm) of the left internal
carotid artery. The reported case confirms that
symptoms of LDS begin to develop at a young age
and thus an early recognition that allows appropri-
ate management and treatment of these patients is
needed (Loeys et al. 2005; Stheneur et al. 2008).
Genetic testing of TGFBR1 and TGFBR2, espe-
cially in cases with mild or inconspicuous facial
dysmorphism, should be regarded as the method
of choice to verify tentative diagnosis of LDS.
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